08:00 , Jan 16, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Infectious disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Infectious disease Mucin 5B oligomeric mucus/gel-forming (MUC5B) Mouse studies suggest maintaining baseline MUC5B expression is necessary to promote the clearance of pathogens from respiratory...
07:00 , Jun 20, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Pulmonary disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Pulmonary disease Pulmonary disease Mucin 5B oligomeric mucus/gel-forming (MUC5B) Patient studies suggest the rs35705950 SNP in the MUC5B promoter region could be a marker of interstitial...
07:00 , May 5, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Pulmonary disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Pulmonary disease Pulmonary fibrosis Mucin 5B oligomeric mucus/gel-forming (MUC5B) A study in patients suggests that MUC5B could be a risk marker of...